Chat with us, powered by LiveChat

Stem Cell Market (Type - Adult Stem Cell, Induced Pluripotent Stem Cell, Human Embryonic Stem Cell, and Other Types; Application - Regenerative Medicine, Neurology, Oncology, Cardiology, and Other Application; End User - Therapeutics Companies, Cell and Tissue Banks, Tools and Reagents Companies, and Service Companies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Stem Cell Market (Type - Adult Stem Cell, Induced Pluripotent Stem Cell, Human Embryonic Stem Cell, and Other Types; Application - Regenerative Medicine, Neurology, Oncology, Cardiology, and Other Application; End User - Therapeutics Companies, Cell and Tissue Banks, Tools and Reagents Companies, and Service Companies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Report Code: HC0592 Category: Healthcare & Medical Devices Published: July, 2019

A recent report published by Infinium Global Research on the stem cell market provides an in-depth analysis of segments and sub-segments in the global as well as regional stem cell market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional stem cell market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global stem cell market. According to the report, the global stem cell market is projected to grow at a CAGR of 11.9% over the forecast period of 2019-2025.

 

Market Insight

A stem cell has a unique ability to develop into specialized cell types in the body depending on the source of stem cells and their biological plasticity. Owing to their ability to transform into the new cell, they can be used to replace cells and tissues that have been damaged or lost due to disease. Stem cell therapy is a unique technique that can be used in tissue regeneration, cardiovascular disease treatment, brain disease treatment, and blood cell regeneration treatment.

 

An increasing number of research and development activities in stem cell therapies are one of the major factor driving the growth of the market. Increasing funding for stem cell research from government and private sector in developing and developed countries are opening new doors for the advanced stem cell therapy that in turn has boosted the market growth. Moreover, the proven efficiency of stem cell therapy in various diseases and disorders such as tissue regeneration, cardiovascular diseases, cell deficiency disorder, and others is another driving factor for the growth of the stem cell market. On the other hand, the high cost associated with the treatment and lack of trained experts can hamper the growth of the market. However, raising awareness about stem cell therapies and favoring regulatory laws can provide better opportunities for the market.

 

Geographically, the stem cell market segmented into North America, Europe, Asia-Pacific, and RoW. North America dominates the stem cell market and anticipated to stay on top of the forecast period. Advanced healthcare facilities and increasing funding for research and development are and well-established reimbursement policies and the presence of major market players are supporting the growth of the market in this region. Europe will stay in the second position in the market, advanced healthcare facilities and rising expenditure on healthcare services are some factors contributing to the growth of the market. The market in Asia-Pacific is expected to grow at a steady rate in the forecast period. Rising awareness about stem cell preservation and increasing healthcare expenditure will contribute to the growth of the market in the forecast period.


Stem Cell Market

 

Segment Covered

The report on the global stem cell market covers segments such as type, application, and end user. On the basis of type, the sub-markets include adult stem cell, induced pluripotent stem cell, human embryonic stem cell, and other types. On the basis of application, the sub-markets include regenerative medicine, neurology, oncology, cardiology, and other application. On the basis of end user, the sub-markets include therapeutics companies, cell and tissue banks, tools and reagents companies, and service companies.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Cellular Engineering Technologies Inc., Advanced Cell Technology, Inc., STEMCELL Technologies Inc., BIOTIME, Inc., Astellas Pharma Inc., BrainStorm Cell Therapeutics, Celgene Corporation, CellGenix GmbH, Genea BioCells, Lonza Group AG, and Other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the stem cell market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.